Once-weekly exenatide in type 2 diabetes

By Parmar Dinesh  

International Journal of Diabetes in Developing Countries, Vol. 31, Iss. 2, 2011-04 ,pp. : 121-122

Springer Publishing Company

Access to resources Recommend Favorite

Clinical experience with exenatide in predominantly Asian and Pacific Islander patients with type 2 diabetes

By Chokrungvaranon Nalurporn  

Endocrine Journal, Vol. 32, Iss. 3, 2007-12 ,pp. : 311-316

Humana Press, Inc

Access to resources Recommend Favorite

A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study

By Nauck M.   Duran S.   Kim D.   Johns D.   Northrup J.   Festa A.   Brodows R.   Trautmann M.  

Diabetologia, Vol. 50, Iss. 2, 2007-02 ,pp. : 259-267

Springer Publishing Company

Access to resources Recommend Favorite

Beta cell mass in diabetes: a realistic therapeutic target?

By Meier J.  

Diabetologia, Vol. 51, Iss. 5, 2008-05 ,pp. : 703-713

Springer Publishing Company

Access to resources Recommend Favorite

Therapeutic Management Strategies for Type 2 Diabetes

By  

Current Diabetes Reviews, Vol. 2, Iss. 3, 2006-08 ,pp. : 339-342

Bentham Science Publishers

Access to resources Recommend Favorite